Above average — CMS composite of the measures below.
Past the typical resurvey interval — a standard survey could occur at any time
Estimate from public CMS data, current as of July 2026. Survey timing is at the state agency's discretion.
Citation history
Health deficiencies cited at Beardstown Health & Rehab Ctr during CMS and state inspections, most recent first.
Two residents with symptoms of a potentially communicable skin condition were treated with Permethrin cream, but the facility did not implement required contact isolation precautions or document infection tracking and follow-up. Staff confirmed that isolation protocols were not followed, and there was no infection preventionist oversight at the time.
The facility failed to document diagnoses and target behaviors to justify the use of antipsychotic medications for six residents with Dementia or Alzheimer's Disease. Staff confirmed that these residents did not exhibit behaviors warranting such medications, and non-pharmacological interventions were effective in managing occasional outbursts.
The facility failed to ensure residents were free from chemical restraints, as evidenced by the inappropriate use of antipsychotic medications for three residents. One resident was administered Haloperidol regularly despite not displaying behaviors that warranted its use. Another resident's Seroquel dosage was increased following a fall, despite not exhibiting behaviors that posed a risk. A third resident's Abilify dosage was increased and Haldol injections were administered during a period of confusion and restlessness associated with a UTI and COVID-19 infection.
The facility failed to follow Enhanced Barrier Precautions for two residents at high risk for infection. An LPN did not wear a gown during wound treatment for one resident and administered medication through a gastrostomy tube for another without proper precautions. The care plans for both residents did not document Enhanced Barrier Precautions.
Failure to Implement Infection Control Measures for Suspected Communicable Skin Condition
Penalty
Summary
The facility failed to implement appropriate infection control measures for residents exhibiting signs and symptoms of a potentially communicable skin condition. Specifically, two residents were treated with Permethrin cream, a medication commonly used for scabies, following the development of rashes and skin lesions. Despite the presence of symptoms consistent with a contagious skin infestation and the use of a topical antiparasitic, there was no documentation that contact isolation precautions were initiated for either resident. The facility's infection control policy requires contact precautions in such cases, including the use of personal protective equipment and isolation measures, but these were not followed. Additionally, the facility did not obtain a clear diagnosis or track the infection, nor did it clarify physician orders through the infection preventionist. Medical records lacked evidence of infection tracking, follow-up assessments, or infection preventionist review. Staff interviews confirmed that the residents' room was not placed on contact isolation during treatment, and the Director of Nursing was unable to locate any documentation of infection control interventions or follow-up. At the time of the survey, the facility did not have an infection preventionist in place.
Failure to Justify Antipsychotic Medication Use
Penalty
Summary
The facility failed to document a diagnosis and target behaviors to warrant the use of antipsychotic medications and did not treat underlying conditions prior to initiating and increasing antipsychotic medication doses for six residents diagnosed with Dementia or Alzheimer's Disease. The facility's policy requires that behavioral symptoms present a danger to the resident or others and that behavioral interventions have been attempted and documented in the care plan. However, the facility did not adhere to these guidelines for the residents in question. For instance, one resident (R27) was on Haloperidol for unspecified psychosis but did not exhibit behaviors that justified its use. The resident's care plan and behavior tracking sheets did not document any psychotic behaviors, and the Social Services Director confirmed that the resident's behaviors were not psychotic in nature. Another resident (R32) had their Seroquel dosage increased due to a fall, but staff confirmed that the resident did not have behaviors warranting the use of the medication. Similarly, R54 was on dual antipsychotic medications without justification, and staff reported that the resident did not exhibit behaviors that would necessitate such treatment. Other residents, such as R57 and R62, also had their antipsychotic medications increased without proper documentation of behaviors that would justify the use of these medications. R57's Abilify was increased despite the resident not exhibiting any behaviors that put them or others at risk. R62's Seroquel was increased due to crying and wandering, which do not justify the use of the medication according to the facility's policy. Lastly, R65 was on Seroquel without documented behaviors to justify its use, and staff confirmed that non-pharmacological interventions were effective in managing the resident's occasional outbursts.
Inappropriate Use of Antipsychotic Medications as Chemical Restraints
Penalty
Summary
The facility failed to ensure residents were free from chemical restraints, as evidenced by the inappropriate use of antipsychotic medications for three residents. Resident R27 was administered Haloperidol regularly despite not displaying behaviors that warranted its use. The medication was initially prescribed for unspecified psychosis, but it was continued even when the resident was calm and cooperative. The resident's care plan and progress notes indicated that the medication was used to manage behaviors such as trying to get up unassisted, which does not justify the use of a chemical restraint according to the facility's policy. Resident R32's Seroquel dosage was increased following a fall, despite the resident not exhibiting behaviors that posed a risk to themselves or others. The increase in medication was attributed to restlessness and agitation, but observations and interviews with staff indicated that the resident's primary behavior was moaning during care. The decision to increase the medication was made without sufficient evidence of severe behavioral issues, thus constituting the use of a chemical restraint. Resident R57's Abilify dosage was increased and Haldol injections were administered during a period of confusion and restlessness associated with a UTI and COVID-19 infection. The resident's behavior of trying to stand up unassisted was managed with antipsychotic medications, despite the absence of severe behavioral symptoms. The facility's records showed that the resident was pleasant and exhibited no behaviors during subsequent observations, indicating that the use of these medications was not justified and amounted to a chemical restraint.
Failure to Follow Enhanced Barrier Precautions
Penalty
Summary
The facility failed to ensure Enhanced Barrier Precautions were followed and care planned for two residents at high risk for infection. Resident 27 had an indwelling urinary catheter and wound treatment orders for the coccyx and left second toe. Despite the presence of a sign indicating Enhanced Barrier Precautions, a Licensed Practical Nurse (LPN) did not wear a gown during the wound treatment and applied a sock to the resident's foot with bare hands after removing gloves. The resident's care plan did not document a plan for Enhanced Barrier Precautions. Similarly, Resident 29, who had a gastrostomy tube, did not have a care plan documenting Enhanced Barrier Precautions. An LPN administered medication through the gastrostomy tube without wearing a gown, despite the requirement for such precautions. The Director of Nursing confirmed that the facility could not provide an updated infection control policy with the new Enhanced Barrier Precaution protocol and acknowledged that the LPN should have worn gloves and a gown during the procedures for both residents.
What surveyors are citing around you — mapped
All 10 risk areas, ranked with evidence
Repeat citations, what's rising near you, and quality measures — ranked so department heads know exactly where to look first.
Illustrative
What surveyors actually found near you
We read the 49 citations issued within 25 miles in the last 12 months — including the 3 immediate-jeopardy cases — and tell you exactly what happened, in plain English, matched to your record.
Resident with a documented fall history left unattended on the patio; found on the ground with a hip fracture.
Walk-in cooler logs missing for 12 days; expired supplements in the medication room fridge.
Illustrative
A prioritized, do-first checklist
Every risk area becomes concrete audit steps drawn from real citations at facilities like yours — run them this week, before your window opens.
Illustrative
Risk indicators are statistical estimates from public CMS data — not predictions, findings, or compliance advice.
Nursing homes near Beardstown
How nearby facilities compare on the same public inspection record.
| Facility | Distance | Overall rating | Citations, 12 mo | Serious (J–L) |
|---|---|---|---|---|
| Rushville Nursing & Rehab Ctr | 10.8 mi | ★★★★★ | 1 | 0 |
| Cass County Senior Living & Rehabilitation Llc | 12.2 mi | ★★★★★ | 16 | 0 |
| Mount Sterling Health And Rehab Center | 18.2 mi | ★★★★★ | 4 | 1 |
| Jacksonville Skld Nur & Rehab | 19.7 mi | ★★★★★ | 2 | 0 |
| Prairie Village Healthcare Ctr | 20 mi | ★★★★★ | 7 | 1 |
Every risk area ranked, a do-first checklist, and your local survey patterns
Built specifically for Beardstown Health & Rehab Ctr.
100% money-back within 48 hours.
Trusted data, never guesswork. Every citation, penalty, rating and Plan of Correction on this page is sourced from public CMS records (latest release July 2026) and official state health department websites.